Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00652028 · ClinicalTrials.gov registry record · Phase 2
Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects
A Phase 2 study of Intubated and Mechanically Ventilated Pediatric Subjects, sponsored by Hospira, now a wholly owned subsidiary of Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 69
- Enrollment target
- 9
- Study locations
NCT00652028 is a Phase 2 study of Intubated and Mechanically Ventilated Pediatric Subjects that has completed, run by Hospira, now a wholly owned subsidiary of Pfizer. The registered enrollment target is 69 participants. The trial reports 9 study locations across 8 states.
The verdict
NCT00652028, a Phase 2 study of Intubated and Mechanically Ventilated Pediatric Subjects, has completed, sponsored by Hospira, now a wholly owned subsidiary of Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 69 participants
- Enrollment target
- 9
- Study locations
Study Summary
The objective of this study is to characterize the pharmacokinetic and pharmacodynamic profile of dexmedetomidine administered as an intravenous loading dose followed by a continuous intravenous infusion in pediatric subjects ages ≥2 through \<17 years old.
Conditions Studied
Interventions
- DRUG Dexmedetomidine, midazolam; fentanyl
Study Locations (9)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
- Children's Hospital of Pittsburgh - Pittsburgh
Florida
- Miami Children's Hospital - Miami
Kentucky
- University of Louisville/Kosair Children's Hospital - Louisville
New York
- Women and Children's Hospital of Buffalo - Buffalo
North Carolina
- Duke University Medical Center - Durham
Ohio
- University Hospitals Medical Center - Cleveland
Virginia
- Virginia Commonwealth University - Richmond
Other
- Unidad Cirugia Cardiovascular de Guatemala - Guatemala City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2008-11 |
| Est. Completion | 2010-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00652028
The ClinicalTrials.gov registry entry for NCT00652028 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospira, now a wholly owned subsidiary of Pfizer, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intubated and Mechanically Ventilated Pediatric Subjects appearing as the primary indexed condition, and to 1 intervention - of which Dexmedetomidine, midazolam; fentanyl is the first listed.
NCT00652028 reports 9 study locations spanning 8 distinct geographic areas - top geographies include Pennsylvania, Florida, Kentucky.
Frequently Asked Questions
What is clinical trial NCT00652028 about?
NCT00652028 is a clinical study titled "Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects". The objective of this study is to characterize the pharmacokinetic and pharmacodynamic profile of dexmedetomidine administered as an intravenous loading dose followed by a continuous intravenous infusion in pediatric subjects ages ≥2 through \<17 years old.
What is the current status of trial NCT00652028?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 69 participants. The study started on 2008-11. Estimated completion is 2010-04.
What conditions does trial NCT00652028 study?
This clinical trial studies the following conditions: Intubated and Mechanically Ventilated Pediatric Subjects.
What interventions are being tested in trial NCT00652028?
The interventions under investigation include: Dexmedetomidine, midazolam; fentanyl (DRUG).
Who is sponsoring clinical trial NCT00652028?
This trial is sponsored by Hospira, now a wholly owned subsidiary of Pfizer, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00652028 being conducted?
This trial has 9 study locations across Florida, Kentucky, New York, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.